Lincoln Pharmaceuticals (LINCOLN.NSE) Q3 2020 Earnings

20AugConfirmed
Q1 1
Q3 2020
5.16
5.5
5.83
6.16

Details

Expected EPS
5.16404432544
Actual EPS
N/A
Surprise EPS
-5.16
Surprise Percent
+100%

Description

Lincoln Pharmaceuticals (LINCOLN.NSE) will report earnings of for Q3 2020 on August 20, 2020.

0 Comments

Share your thoughts